Search results
The True Obesity Paradox: Obese and Malnourished?
Added:
1 year ago
Original Research
Added:
1 year ago
Source:
Heart Failure 2024
Heart Failure Congress 2024 has unveiled 8 Late-breaking trial sessions for 2024.Heart Failure 2024 will take place at the Lisbon Congress Center in May. Access the full Programme here.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators, and keep up to date with our Late-Breaker Discussions with Dr Van Spall.Late…
View more
HFpEF in Patients Living with COPD
Added:
1 month ago
Original Research
VAC in HFpEF: Trends and Challenges
Added:
4 months ago
Review Article
Added:
7 months ago
Source:
Radcliffe Cardiology
A new nationwide cohort study from France suggests that a simple risk stratification tool based on administrative data could help tailor cardiologist follow-up for patients with heart failure (HF), potentially improving survival and optimising resource use. The study found that 40% of patients with HF do not have an annual cardiology consultation, regardless of their disease severity.¹The French…
View more
Added:
11 months ago
This comprehensive video series has been designed to enhance your understanding of heart failure (HF) management. Through expert discussions, we explore the real-world adoption of novel guideline-directed medical therapies (GDMTs) and their impact on patient care. We also delve into the benefits of natriuretic peptide (NP) testing, highlighting how it aids in more accurate and rapid diagnosis,…
View more
Added:
6 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and…
View more
Added:
7 months ago
Source:
Radcliffe Cardiology
The global economic burden of heart failure (HF) reached an estimated $284.17 billion in 2021, highlighting a substantial and growing financial strain on healthcare systems and societies worldwide. A new systematic review reveals that indirect costs, such as productivity loss, now account for over half of this total, signalling a significant shift in the economic impact of the condition…
View more
Coronary Revascularisation in HFrEF
Added:
1 year ago
Review Article
Added:
1 year ago
ACC 25 - Findings of the MIGHTy-Heart study shows no difference between mobile integrated healthcare and a traditional transitions of care coordinator approach in 30-day all-cause readmissions or health status.Dr Ruth Masterson Creber (Columbia University, New York, US) joins us onsite at ACC to discuss the findings from MIGHTy-Heart, a comparative effectiveness study that evaluated two different…
View more